OpenAI invests in Sam Altman's brain computer interface startup Merge Labs (techcrunch.com)

OpenAI has made a significant investment in Merge Labs, a startup co-founded by Sam Altman, that aims to develop a noninvasive brain-computer interface (BCI) using innovative technologies connecting neurons with molecules, rather than traditional electrodes. Merge Labs recently emerged from stealth mode after securing a $250 million seed round, with OpenAI reportedly contributing the largest share at a valuation of $850 million. The startup’s goal is to enhance human capabilities by interfacing with the brain, which could enable the restoration of lost abilities and deepen human-AI collaboration. This investment positions Merge Labs in direct competition with Elon Musk's Neuralink, which utilizes invasive methods for its BCI technology. While Neuralink's approach involves surgical implantation, Merge Labs emphasizes a noninvasive route, potentially making BCI technology more accessible. The collaboration with OpenAI will leverage advances in AI to enhance research and development in neuroscience and bioengineering, highlighting the potential for AI to interpret neural intent and improve interaction reliability. This partnership not only aligns with Altman’s vision of merging human and machine intelligence but also reinforces OpenAI’s strategy of fostering advancements that could lead to superhuman capabilities.